When was Scinovia founded?

Scinovia was founded in 2014 and raised its 1st funding round 6 years after it was founded.

Where is Scinovia located?

Scinovia is headquartered in Durham, United States. It is registered at 8801 FAST PARK DR, STE 301, STE 301, RALEIGH, NC.

How many employees does Scinovia have?

As of Dec 31, 2021, the latest employee count at Scinovia is 10.

Is Scinovia a funded company?

Scinovia is a funded company, having raised a total of $6.91M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jan 28, 2020.

How much is Scinovia worth?

The latest valuation of Scinovia is $***** as of Aug 10, 2022.

When was the latest funding round of Scinovia?

Scinovia's latest funding was a $***** Series A round on Sep 12, 2022, with participation from 0 investor. Its primary sector is Surgical Instruments. In United States, the Surgical Instruments sector has seen $152M in funding in 2026 to date.

Where does Scinovia rank among its competitors?

Scinovia ranks 7th amongst 18 active competitors, of which 10 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was Bayou Surgical, which secured $5M in Oct, 2025.

Who are the top competitors of Scinovia?

Scinovia's top competitors include Haemonetics, VISIE and Sisu Global Health. Among them, Bayou Surgical secured the most recent funding round in October, 2025.

Scinovia - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of an augmented-reality-based surgical camera. The company is developing an imaging device for surgeons to visualize blood flow during surgery. Surgeons can immediately point shoot an image to visualize the adequacy of blood flow in surgeries, especially in heart bypass, cardiovascular, plastics, and cancer removal.

Website: scinovia.com
Registered Address: 8801 FAST PARK DR, STE 301, STE 301, RALEIGH, NC

Key Metrics

Founded Year

2014

Location

Durham, United States

Stage

Series A

Total Funding

$6.91M in 2 rounds

Latest Funding Round

Series A, Sep 12, 2022, $*****

Post Money Valuation

$***** as on Aug 10, 2022

Ranked

7^th among 18 active competitors

Employee Count

10 as on Dec 31, 2021

Similar Companies

Haemonetics & 19 more

View Scinovia's full profile

Scinovia is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Scinovia Corp CIN: 0001627490 , United States, Active		$1 - $1M (As on Sep 12, 2022)	10 (As on Dec 31, 2021)	-

Scinovia has raised a total funding of $6.91M over 2 rounds. Its first funding round was on Jan 28, 2020.

Here is the list of recent funding rounds of Scinovia:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 12, 2022	9423532	Series A	2262640	7629124	4662611	2159196
Jan 28, 2020	8618425	Series A	9591634	8501312	9817055	6712691

Access funding benchmarks and valuations. Sign up today!

View details of Scinovia's funding rounds and investors

The founders of Scinovia is Jim Sund.

Here are the details of Scinovia's key team members:

Jim Sund: Founder & CEO of Scinovia.
Contact Info: 1 email address

View details of Scinovia's Founder profiles and Board Members

Scinovia's employee count trend

Scinovia has 10 employees as of Dec 21. Here is Scinovia's employee count trend over the years:

Uncover Scinovia's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Scinovia include Haemonetics, VISIE and Sisu Global Health. Here is the list of Top 10 competitors of Scinovia, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Haemonetics 1971, Braintree (United States), Public	Provider of hematology products and solutions for the medical industry	-	Blum Capital, Partners For Growth & 1 others	62/100
2nd	VISIE 2017, Austin (United States), Series A	Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery	$12.7M	Capital Factory, Medingenii & 7 others	52/100
3rd	Sisu Global Health 2014, Baltimore (United States), Seed	Provider of intraoperative autotransfusion device	$3.1M	Dreamit, Michbelles & 23 others	39/100
4th	Gausssurgical.com 2011, Los Altos (United States), Acqui-Hired	AI-powered medical device for perioperative care	$60.2M	Allumia Ventures, Promus Ventures & 13 others	38/100
5th	Haermonics 2015, Amsterdam (Netherlands), Series A	A drainage and flushing system for postoperative pericardial flushing	$4.41M	Invest-NL, BOM & 3 others	37/100
6th	Gate Science 2020, Boston (United States), Seed	Developer of a multi-modal device for post-surgery pain	$150K	-	34/100
7th	Scinovia 2014, Durham (United States), Series A	Provider of an augmented-reality-based surgical camera	$6.91M	-	32/100
8th	i-sep 2015, Nantes (France), Series A	Cell salvage solutions for autologous blood transfusion during surgery	$3.61M	GO CAPITAL	32/100
9th	Perfusio 2014, Greenville (United States), Series A	Developer of the blood-flowing imaging device for surgeries	$11.3M	National Heart Lung and Blood Institute, HHS	31/100
10th	Bayou Surgical 2016, Houston (United States), Series A	Developer of a medical device to improve visualization during surgical procedures	$5M	-	30/100